Brainomix announced a new strategic partnership today with Medtronic’s Neurovascular business unit, a collaboration aimed at improving stroke care across Western Europe. The companies intend to integrate artificial intelligence (AI) solutions into clinical practice to expand access to critical, life-saving treatments.
UK-based Brainomix is the developer of the 360 Stroke platform. It uses cutting-edge AI algorithms to provide real-time interpretations of brain scans, supporting more informed decisions about treatment and patient transfers for those affected by stroke. The company believes this partnership represents a significant step forward, combining Brainomix’s AI-powered imaging technology with Medtronic’s expertise in neurovascular treatments. This collaboration could pave the way for faster and more accurate diagnoses, leading to better-informed decisions. Ultimately, it could help facilitate more efficient, life-saving interventions for healthcare professionals.
Brainomix says Medtronic’s established presence in Western Europe will help accelerate the adoption of its AI technology, ensuring that innovative solutions reach more hospitals and other healthcare providers throughout the region. Furthermore, by integrating AI-powered imaging software with Medtronic’s neurovascular solutions, the partnership could create highly precise diagnostic tools. These tools, in turn, would enable quicker and more informed decision-making, which is crucial for the timely treatment of stroke patients. The collaboration should also optimize clinical workflows, potentially alleviating the burden on providers and enhancing overall efficiency.
“This partnership with Medtronic is a natural fit, with the leading neurovascular device provider joining forces with the leading stroke AI imaging partner, both aligned around a mutual commitment towards improving stroke care for all patients,” said Dr. Michalis Papadakis, CEO and co-founder of Brainomix. “We have demonstrated that our software impacts treatment rates, and working with Medtronic, we now have an opportunity together to deliver a solution for stroke networks across Europe that will enable more patients to get access to vital stroke treatments.”
